Topics

Glioblastoma | Prognosis | Neutrophil-to-Lymphocyte Ratio

Home > Publications > Topics > Glioblastoma > Prognosis > NLR

Zemskova O, Yu NY, Leppert J, Löser A, Rades D.
Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?
In Vivo. 2024 Aug 26;38(5):2341-2348. doi: 10.21873/invivo.13700. PMID: 39187342. Observational study. ˍ

Mohammad AH, Sakalla R, Davalan W, Ruiz-Barerra MA, Jatana S, Khalaf R, Li H, Aberra R, Al-Saadi T, Diaz RJ.
Rise in post-resection neutrophil-to-lymphocyte ratio correlates with decreased survival in glioblastoma patients.
Neurooncol Adv. 2025 Jan 23;7(1):vdaf014. doi: 10.1093/noajnl/vdaf014. PMID: 40051660. Observational study. ˍ

Chung MW, Tzeng CC, Huang YC, Wei KC, Hsu PW, Chuang CC, Lin YJ, Chen KT, Lee CC.
Neutrophil-to-lymphocyte ratio dynamics: prognostic value and potential for surveilling glioblastoma recurrence.
BMC Cancer. 2025 Apr 16;25(1):709. doi: 10.1186/s12885-025-14118-8. PMID: 40241016. Observational study. ˍ